- Home
- GF vs CATX Comparison
GF vs CATX Comparison
Compare GF & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- CATX
- Stock Information
- Founded
- GF 1990
- CATX 1983
- Country
- GF Germany
- CATX United States
- Employees
- GF N/A
- CATX N/A
- Industry
- GF Investment Managers
- CATX Medical/Dental Instruments
- Sector
- GF Finance
- CATX Health Care
- Exchange
- GF Nasdaq
- CATX Nasdaq
- Market Cap
- GF 167.2M
- CATX 183.2M
- IPO Year
- GF N/A
- CATX N/A
- Fundamental
- Price
- GF $10.07
- CATX $2.22
- Analyst Decision
- GF
- CATX Strong Buy
- Analyst Count
- GF 0
- CATX 11
- Target Price
- GF N/A
- CATX $15.30
- AVG Volume (30 Days)
- GF 28.1K
- CATX 562.0K
- Earning Date
- GF 01-01-0001
- CATX 03-26-2025
- Dividend Yield
- GF 0.82%
- CATX N/A
- EPS Growth
- GF N/A
- CATX N/A
- EPS
- GF N/A
- CATX N/A
- Revenue
- GF N/A
- CATX $1,454,000.00
- Revenue This Year
- GF N/A
- CATX N/A
- Revenue Next Year
- GF N/A
- CATX $1.15
- P/E Ratio
- GF N/A
- CATX N/A
- Revenue Growth
- GF N/A
- CATX 1.40
- 52 Week Low
- GF $7.38
- CATX $2.19
- 52 Week High
- GF $9.41
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- GF 57.31
- CATX 33.93
- Support Level
- GF $10.14
- CATX $2.32
- Resistance Level
- GF $10.28
- CATX $2.62
- Average True Range (ATR)
- GF 0.14
- CATX 0.18
- MACD
- GF -0.07
- CATX 0.00
- Stochastic Oscillator
- GF 32.56
- CATX 4.84
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.